Bayer Ag · XETR:BAYN
Bayer — Non-Deal Roadshow (January 2025)
15 slides from Bayer's roadshow presentation, January 2025
Slide 1: Corporate Governance Roadshow
///////////// Health for all, Hunger for none Corporate Governance Roadshow January 2025
Slide 2: Cautionary Statements Regarding Forward-Looking Information
Cautionary Statements Regarding Forward-Looking Information This presentation may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the ac
Slide 3: Agenda
Business & Strategy Supervisory Board BoM Compensation AGM Format Sustainability Agenda Pharmaceuticals Business & Strategy Supervisory Pharmaceuticals Board Board of Management Pharmaceuticals Compensation Pharmaceuticals AGM Format Pharmaceuticals Sustainability 3 /// Bayer Corporate Governance Ro
Slide 4: Key Topics
Business & Strategy Supervisory Board BoM Compensation AGM Format Sustainability Key Topics Led by our CEO Bill Anderson, Bayer began a multi-year restructuring of our business in 2024 We have made progress on key strategic focus areas but understand there is a lot of work to do We have set clear pr
Slide 5: Advancing Our Key Strategic Priorities
Business & Strategy Supervisory Board BoM Compensation AGM Format Sustainability Advancing Our Key Strategic Priorities We are underway on a three-year plan to address the four key priorities identified by our new CEO at our 2024 Capital Markets Day 2024 2025 2026 Ongoing Identified challenges Advan
Slide 6: Driving Growth and Innovation Across Divisions
Business & Strategy Supervisory Board BoM Compensation AGM Format Sustainability Driving Growth and Innovation Across Divisions We are building momentum in Pharma and remaining resilient in Crop Science despite market pressures Pharmaceuticals Pharmaceuticals Crop Science Pharmaceuticals Renewing To
Slide 7: Managing Litigation Risk
Business & Strategy Supervisory Board BoM Compensation AGM Format Sustainability Managing Litigation Risk We are actively addressing litigation risk on Roundup and PCB through a multi-faceted approach to protect our liquidity, resolve claims at scale, and contain our exposure Workstreams Process and
Slide 8: Improving Cash Flow and Deleveraging
Business & Strategy Supervisory Board BoM Compensation AGM Format Sustainability Improving Cash Flow and Deleveraging In 2024, Bayer resolved to pay out the legally required minimum dividend for three years Distribution for 2024 was approved by shareholders at the AGM; Bayer will continue to request
Slide 9: Dynamic Shared Ownership
Business & Strategy Supervisory Board BoM Compensation AGM Format Sustainability Dynamic Shared Ownership Our new operating model yields cost efficiencies, greater customer centricity and increased innovation speed while maintaining optionality; we are achieving this through reduction of bureaucracy
Slide 10: Refreshed Supervisory Board
Business & Strategy Supervisory Board BoM Compensation AGM Format Sustainability Refreshed Supervisory Board Supervisory Board composition aligned with Bayer’s go-forward strategy Prof. Dr. Norbert Winkeljohann Chairman Tenure Extensive global experience in management, auditing and consulting 0 - 3
Slide 11: Seeking Opportunities to Add Skills to the Supervisory Board
Business & Strategy Supervisory Board BoM Compensation AGM Format Sustainability Seeking Opportunities to Add Skills to the Supervisory Board As part of our ongoing evaluation process and to align with our business restructuring, the Supervisory Board has identified two key focus areas to consider i
Slide 12: Board of Management Compensation System
Business & Strategy Supervisory Board BoM Compensation AGM Format Sustainability Board of Management Compensation System Shareholders approved our updated BoM Compensation System with 93% support at our 2024 Annual Meeting Base Salary Fixed compensation Indicates New / Substantially Adjusted Compone
Slide 13: Feedback on Annual Meeting Format
Business & Strategy Supervisory Board BoM Compensation AGM Format Sustainability Feedback on Annual Meeting Format In 2025, Bayer is considering seeking a refresh of the 2-year authorisation approved by shareholders in 2023 to potentially use virtual meetings Benefits of holding our Annual Stockhold
Slide 14: Progress on Sustainability Targets
Business & Strategy Supervisory Board BoM Compensation AGM Format Sustainability Progress on Sustainability Targets Tracking towards our concrete 2030 sustainability targets with our mission: Health for all, Hunger for none Our Business Impact Climate Action on UN SDGs Pharmaceuticals Our impact on
Slide 15: Climate Transition and Transformation Plan
Business & Strategy Supervisory Board BoM Compensation AGM Format Sustainability Climate Transition and Transformation Plan Our plan, published in June 2024, details our roadmap to achieving net zero by 2050 I. Transition toward Net Zero II. Transformation to New Value Pools Aligned with the Paris A